ExLibris header image
SFX Logo
Title: Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Wischik, C M yr:1996


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Medina, David X. "Methylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity." Brain pathology 21.2 (2011): 140-149. Link to Full Text for this item Link to SFX for this item
2. Wischik, Staff R. "Challenges in the Conduct of Disease-Modifying Trials in AD: Practical Experience from a Phase 2 Trial of Tau-Aggregation Inhibitor Therapy." The Journal of Nutrition, Health & Aging 13.4 (2009): 367-9. Link to SFX for this item
3. CROWE, A. "High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation." Biochemical and biophysical research communications 358.1 (2007): 1-6. Link to SFX for this item
4. Taniguchi, S. "Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins." The Journal of biological chemistry 280.9 (2004): 7614-7623. Link to SFX for this item
5. Gozes, I. "NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP)." CNS drug reviews 11.4 (2005): 353-68. Link to Full Text for this item Link to SFX for this item
6. Gura, T. "Hope in Alzheimer's fight emerges from unexpected places." Nature medicine 14.9 (2008): 894-894. Link to Full Text for this item Link to SFX for this item
7. Ganzach, Y. "Intelligence and the repayment of high- and low-consequences debt." Personality and Individual Differences 110 (2017): 102-108. Link to SFX for this item
8. Vargas, R. "Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery." British Journal of Pharmacology 109.3 (1993): 612-617. Link to Full Text for this item Link to SFX for this item
9. Jackson, Cristian R. "Tau Oligomers Impair Memory and Induce Synaptic and Mitochondrial Dysfunction in Wild-type Mice." Molecular neurodegeneration 6.1 (2011): 39-39. Link to Full Text for this item Link to SFX for this item
10. LaFerla, Frank M. "Pathways linking Abeta and tau pathologies." Biochemical Society transactions 38.4 (2010): 993-995. Link to SFX for this item
11. Michaud, J. "Inhibitory Role of Sphingosine 1-Phosphate Receptor 2 in Macrophage Recruitment during Inflammation." The journal of immunology 184.3 (2010): 1475-1483. Link to SFX for this item
12. Calissano, P. "Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease." Developmental Neurobiology 70.5 (2010): 372-383. Link to Full Text for this item Link to SFX for this item
13. Jicha, G A. "Altered conformation of recombinant frontotemporal dementia-17 mutant tau proteins." Neuroscience Letters 260.3 (1999): 153-6. Link to Full Text for this item Link to SFX for this item
14. Xia, L. "Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms." British journal of pharmacology 155.3 (2008): 387-94. Link to Full Text for this item Link to SFX for this item
15. Castillo, GM. "Laminin inhibition of beta-amyloid protein (A beta) fibrillogenesis and identification of an A beta binding site localized to the globular domain repeats on the laminin A chain." Journal of neuroscience research 62.3 (2000): 451-462. Link to Full Text for this item Link to SFX for this item
16. Robinson, Stephen R. "Lessons from the AN 1792 Alzheimer vaccine: Lest we forget." Neurobiology of Aging 25.5 (2004): 609-615. Link to SFX for this item
17. Holmes, C. "Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial." The lancet 372.9634 (2008): 216-223. Link to SFX for this item
18. Adessi, C. "Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease." The Journal of biological chemistry 278.16 (2003): 13905-13911. Link to SFX for this item
19. N, M. "QSAR modeling of the MAO inhibitory activity of xanthones derivatives." Bioorganic & medicinal chemistry letters 14.22 (2004): 5611-7. Link to SFX for this item
20. Bureau, G. "Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation." Journal of neuroscience research 86.2 (2007): 403-10. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced